Rtsun SP 100mg/500mg/25mg Tablet

Introduction

Rtsun SP is a prescription medication that contains three active ingredients: Artesunate, Sulphadoxine, and Pyrimethamine. It is a combination medication used primarily for the treatment of malaria.

Uses

Rtsun SP is prescribed to treat uncomplicated malaria caused by Plasmodium falciparum, a parasite transmitted through mosquito bites. It is effective in both adults and children and is commonly used in areas where malaria is prevalent.

Dosage and Administration

The dosage of Rtsun SP should be determined by a healthcare professional based on the patient’s age, weight, and severity of the infection. It is typically taken orally with a glass of water, preferably after meals to minimize stomach upset.

Mechanism of Action

Rtsun SP works by targeting different stages of the malaria parasite’s life cycle. Artesunate, a derivative of artemisinin, acts by damaging the parasite’s cell membranes and interfering with its metabolic processes. Sulphadoxine and Pyrimethamine work together to inhibit the synthesis of folate, a vital nutrient for the parasite’s growth and replication.

Side Effects

Common side effects may include nausea, vomiting, headache, dizziness, and abdominal pain. These side effects are usually mild and temporary. However, if they persist or worsen, consult a healthcare professional.

Serious side effects of Rtsun SP are rare but can occur. These may include severe allergic reactions, such as rash, itching, swelling, or difficulty breathing. If any of these symptoms occur, immediate medical attention should be sought.

Drug Interactions

Rtsun SP may interact with certain medications, potentially affecting their efficacy or increasing the risk of side effects. Inform your healthcare provider about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements.

Some common drug interactions to be aware of include anticoagulants (blood thinners), certain anticonvulsants, and certain antibiotics. It is best to consult with your healthcare provider or pharmacist for a complete list of potential drug interactions.

Precautions

Before starting Rtsun SP, inform your healthcare provider about any known allergies or sensitivities to Artesunate, Sulphadoxine, Pyrimethamine, or any other medications. Disclose your medical history, especially if you have kidney or liver problems.

Rtsun SP should be used with caution in pregnant women, as the safety of the medication during pregnancy has not been fully established. It is recommended to discuss the potential risks and benefits with a healthcare professional before using this medication during pregnancy.

Storage

Patient Tips

• Take Rtsun SP exactly as prescribed by your healthcare provider. Do not exceed the recommended dosage or duration of treatment.
• If you experience any unusual or severe side effects, contact your healthcare provider immediately.
• Complete the full course of treatment, even if you start feeling better before the treatment is finished.
• Use additional protective measures, such as mosquito nets and insect repellents, to prevent mosquito bites while taking Rtsun SP.
• If you miss a dose, take it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Artesunate (Drugs.com) [Accessed 28 Jun. 2024] (online) Available at:
• artesunate 110 mg intravenous solution antimalarial drugs (RX) [Accessed 3 Jun. 2024] (online) Available at:
• Malaria (MedlinePlus) [Accessed 29 Jun. 2024] (online) Available at:
• Li ZJ, Dai HQ, Huang XW, Feng J, Deng JH, Wang ZX, Yang XM, Liu YJ, Wu Y, Chen PH, Shi H, Wang JG, Zhou J, Lu GD. Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma. Acta Pharmacol Sin. 2021 Feb;42(2):301-310. doi: 10.1038/s41401-020-0478-3. Epub 2020 Jul 22. [Accessed 1 Jun. 2024] Available at: